Smoking prevalence and its impacts on lung cancer mortality in Sub-Saharan Africa: An epidemiological study

Preventive Medicine

Volumn 57, Issue 5, 2013, Pages 634-640

  Winkler, Volker ^a   Ott, Jördis J ^b   Cowan, Melanie ^b   Becher, Heiko ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Africa; Epidemiologic model; Lung cancer; Mortality; Smoking prevalence

Indexed keywords

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ARTICLE; BENIN; CANCER MORTALITY; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HEALTH SURVEY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALAWI; MALE; NIGER; PREVALENCE; PRIORITY JOURNAL; REFERENCE DATABASE; RISK FACTOR; SEX DIFFERENTIATION; SMOKING; SMOKING CESSATION; STATISTICAL MODEL; SWAZILAND; VALIDATION STUDY;

AFRICA; AGE-STANDARDIZED RATE; ASR; EPIDEMIOLOGIC MODEL; IARC; INTERNATIONAL AGENCY FOR RESEARCH ON CANCER; LMICS; LOW AND MIDDLE INCOME COUNTRIES; LUNG CANCER; MORTALITY; RELATIVE RISK; RR; SMOKING PREVALENCE;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HEALTH SURVEYS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84885865803     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.08.022     Document Type: Article

References (34)

1. Ando M., Wakai K., Seki N., et al. Attributable and absolute risk of lung cancer death by smoking status: findings from the Japan Collaborative Cohort Study. Int. J. Cancer 2003, 105:249-254.
2. Becher H., Winkler V. Lung cancer mortality in Sub-Saharan Africa. Int. J. Cancer 2011, 129:1537-1539. (author reply 40).
3. Brennan P., Bray I. Recent trends and future directions for lung cancer mortality in Europe. Br. J. Cancer 2002, 87:43-48.
4. Brown C.C., Kessler L.G. Projections of lung cancer mortality in the United States: 1985-2025. J. Natl. Cancer Inst. 1988, 80:43-51.
5. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50years' observations on male British doctors. BMJ 2004, 328:1519.
6. El Ghissassi F., Baan R., Straif K., et al. A review of human carcinogens-part D: radiation. Lancet Oncol. 2009, 10:751-752.
7. Epstein R.J., Zhao Y. Racial differences in lung cancer. N. Engl. J. Med. 2006, 354:1951-1953. (author reply 51-3).
8. Fallah M., Kharazmi E. Substantial under-estimation in cancer incidence estimates for developing countries due to under-ascertainment in elderly cancer cases. Cancer Lett. 2008, 264:250-255.
9. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127:2893-2917.
10. French D., Catney D., Gavin A.T. Modelling predictions of cancer deaths in Northern Ireland. Ulster Med. J. 2006, 75:120-125.
11. Haiman C.A., Stram D.O., Wilkens L.R., et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N. Engl. J. Med. 2006, 354:333-342.
12. IARC Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2004, WHO, Lyon. IARC (Ed.).
13. Jha P., Ranson M.K., Nguyen S.N., Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am. J. Public Health 2002, 92:1002-1006.
14. Johansson M., Relton C., Ueland P.M., et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010, 303:2377-2385.
15. Knorr-Held L., Rainer E. Projections of lung cancer mortality in West Germany: a case study in Bayesian prediction. Biostatistics 2001, 2:109-129.
16. Kuper H., Boffetta P., Adami H.O. Tobacco use and cancer causation: association by tumour type. J. Intern. Med. 2002, 252:206-224.
17. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
18. Negri E., La Vecchia C., Decarli A., Boyle P. Projections to the end of the century of mortality from major cancer sites in Italy. Tumori 1990, 76:420-428.
19. Ng N., Winkler V., Van Minh H., Tesfaye F., Wall S., Becher H. Predicting lung cancer death in Africa and Asia: differences with WHO estimates. Cancer Causes Control 2009, 20:721-730.
20. Perez-Stable E.J., Herrera B., Jacob P., Benowitz N.L. Nicotine metabolism and intake in black and white smokers. JAMA 1998, 280:152-156.
21. Smith B.D., Smith G.L., Hurria A., Hortobagyi G.N., Buchholz T.A. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J. Clin. Oncol. 2009, 27:2758-2765.
22. Straif K., Benbrahim-Tallaa L., Baan R., et al. A review of human carcinogens-part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009, 10:453-454.
23. Thun M.J., Henley S.J., Burns D., Jemal A., Shanks T.G., Calle E.E. Lung cancer death rates in lifelong nonsmokers. J. Natl. Cancer Inst. 2006, 98:691-699.
24. UN World population prospects: the 2008 revision. Department of Economic and Social Affairs 2009, UN, New York. P.D. (Ed.).
25. Wakelee H.A., Chang E.T., Gomez S.L., et al. Lung cancer incidence in never smokers. J. Clin. Oncol. 2007, 25:472-478.
26. WHO The Global Burden of Disease 2004 Update 2008, WHO, Geneva.
27. WHO STEPwise approach to surveillance, Geneva 2008.
28. Winkler V., Gbangou A., Kouyate B., Becher H. A simple method to estimate tobacco-related lung cancer deaths based on smoking prevalence data. Methods Inf. Med. 2006, 45:397-403.
29. Winkler V., Ng N., Tesfaye F., Becher H. Predicting lung cancer deaths from smoking prevalence data. Lung Cancer 2011, 74:170-177.
30. Wrensch M.R., Miike R., Sison J.D., et al. CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. Int. J. Cancer 2005, 113:141-147.
31. Yabroff K.R., Bradley C.J., Mariotto A.B., Brown M.L., Feuer E.J. Estimates and projections of value of life lost from cancer deaths in the United States. J. Natl. Cancer Inst. 2008, 100:1755-1762.
32. Yang L., Parkin D.M., Ferlay J., Li L., Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol. Biomarkers Prev. 2005, 14:243-250.
33. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
34. Zaridze D.G., Peto R. Tobacco: A Major International Health Hazard 1986, WHO, Lyon. IARC (Ed.).